GT
GMO

Glenmede Trust’s General Moly, Inc. GMO Stock Holding History

Glenmede Trust’s Portfolio GMO Stock Details GMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,500
Closed -$2K – 2355
2013
Q3 		$2K Sell
1,500
-2,000
-57% -$3.61K ﹤0.01% 2141
2013
Q2 		$6K Buy
+3,500
New +$6.89K ﹤0.01% 1979

Other funds holding GMO

CCM
Coghill Capital Management Chicago, Illinois $3.63M AUM 18.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Glenmede Trust's GMO Position: Q4 2013 in Review

Glenmede Trust sold out of General Moly, Inc. (GMO) in Q4 2013, closing a stake of 1,500 shares — an estimated $2K sold.

Glenmede Trust first reported a position in GMO in Q2 2013 and held it in 2 quarters. The position peaked at $6K in Q2 2013. 57 funds tracked by Wall St. Rank hold GMO as of Q4 2013.

  • Glenmede Trust reported no remaining General Moly, Inc. position as of Q4 2013 after selling out during the quarter.
  • Glenmede Trust sold 1,500 General Moly, Inc. shares in Q4 2013, an estimated $2K.
  • Glenmede Trust first reported a position in General Moly, Inc. in Q2 2013 and held it in 2 quarters.
  • Glenmede Trust's General Moly, Inc. position peaked at $6K in Q2 2013.
  • 57 funds tracked by Wall St. Rank held General Moly, Inc. as of Q4 2013.

Based on Glenmede Trust's 13F filing for Q4 2013, filed 31 Jan 2014.